Ehler Andreas, Benz Joerg, Rudolph Markus G
Therapeutic Modalities, Innovation Center Basel, F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Acta Crystallogr D Struct Biol. 2025 Aug 1;81(Pt 8):436-450. doi: 10.1107/S2059798325005728. Epub 2025 Jul 28.
Fatty acid-binding protein isoforms 4 and 5 are potential diabetes and atherosclerosis targets. During a drug-design program aiming at dual isoform-specific FABP4/5 inhibitors with little or no affinity for FABP3, a set of crystal structures with a median resolution of 1.2 Å was generated. The chemical space of the ligands covers various series in which the carboxylate and aliphatic groups of the natural fatty-acid ligands have been replaced by other moieties. A summary of binding modes of the chemical series is also given with respect to how isoform specificity was achieved. Additionally, several bromine-containing ligands were identified that allowed SAD phasing, yielding an independent experimental confirmation of their chemical composition.
脂肪酸结合蛋白亚型4和5是糖尿病和动脉粥样硬化的潜在靶点。在一个旨在设计对FABP4/5具有双重亚型特异性抑制作用且对FABP3亲和力很小或无亲和力的药物设计项目中,生成了一组中位分辨率为1.2 Å的晶体结构。配体的化学空间涵盖了多个系列,其中天然脂肪酸配体的羧酸盐和脂肪族基团已被其他基团取代。还给出了化学系列结合模式的总结,涉及如何实现亚型特异性。此外,还鉴定出了几种含溴配体,可用于单波长反常散射法(SAD)相位分析,从而对其化学成分进行独立的实验确认。